Top Navigation (EN)

Soricimed has been issued our 7th US Patent

December 25, 2012

Soricimed is pleased to announce the issuing of our 7th US patent by the United States Patent and Trademark Office, issued December 25th 2012.


  To date our patent status is as follows:Soricimed owns all of the intellectual property surrounding the soricidin platform. There are seven US patents issued by the United States Patent and Trademark Office (US 7,119,168; 7,273,850; 7,485,622; 7,745,588; 8,003,754; 8,211,857; 8,338,136).  We hold the European regional patent (1601691) that has also been successful in all eight countries where we pursued the national phase.